National Academies Press: OpenBook

Sequence-Based Classification of Select Agents: A Brighter Line (2010)

Chapter: Appendix B: Committee Member and Staff Biographies

« Previous: Appendix A: Statement of Task
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

Appendix B
Committee Member and Staff Biographies

CHAIR

Dr. James W. LeDuc directs the Program on Global Health in the Institute for Human Infections and Immunity at the University of Texas Medical Branch. He also serves as deputy director of the Galveston National Laboratory. Previously, he served as the coordinator for influenza for the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, and was the director of the Division of Viral and Rickettsial Diseases in the CDC National Center for Infectious Diseases (NCID). He began his professional career as a field biologist with the Smithsonian Institution’s African Mammal Project in West Africa. He then served for 23 years as an officer in the U.S. Army Medical Research and Development Command. He joined CDC in 1992, was assigned to the World Health Organization as a Medical Officer, and later became the associate director for global health at NCID. His research interests include the epidemiology of arboviruses and viral hemorrhagic fevers and global health. He has participated in a number of National Research Council studies.

MEMBERS

Dr. Ralph Baric received his BS from North Carolina State University in 1977. He obtained his PhD from the Department of Microbiology of North Carolina State University in 1982, studying alpha-virus–host interaction and pathogenesis under the direction of Robert E. Johnston. He continued his postdoctoral training on coronavirus replication and pathogenesis under the direction of Michael M. C. Lai at the University of Southern California. In 1986, Dr. Baric was hired as an assistant professor in the Department of Parasitology and Laboratory Practice, and he is currently a professor in the Department of

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

Epidemiology and the Department of Microbiology and Immunology of the University of North Carolina at Chapel Hill. During his early training, Dr. Baric was a Harvey Weaver Scholar for the National Multiple Sclerosis Society and an established investigator for the American Heart Association in association with his studies of coronavirus replication, cross-species transmission, persistence, evolution, and pathogenesis. He is a member of the Editorial Board of the Journal of Virology and a senior editor for PLoS Pathogens. Dr. Baric is a permanent member of a National Institutes of health (NIH) study section (VirB); has been a consultant for the World Health Organization, the Centers for Disease Control and Prevention, and NIH; and has served on various institutional recombinant-DNA review committees. He has published over 130 peer-reviewed manuscripts, including several in Science, the Proceedings of the National Academy of Sciences of the United States of America, and Nature Medicine, and his research efforts are supported by several NIH research grants. Dr. Baric’s expertise is primarily in norovirus molecular evolution and susceptibility and in coronavirus reverse genetics, synthetic genome reconstruction, pathogenesis, vaccine design, and cross-species transmission of viruses, often using the SARS coronavirus or noroviruses as models.


Dr. Roger G. Breeze received his veterinary degree in 1968 and his PhD in veterinary pathology in 1973, both from the University of Glasgow, Scotland. He was engaged in teaching, diagnostic pathology, and research on respiratory and cardiovascular diseases at the University of Glasgow Veterinary School from 1968 to 1977 and at Washington State University College of Veterinary Medicine from 1977 to 1987, where he was professor and chair of the Department of Microbiology and Pathology. From 1984 to 1987, he was deputy director of the Washington Technology Center, the state’s high-technology sciences initiative, based in the College of Engineering of the University of Washington. In 1987, he was appointed director of the U.S. Department of Agriculture (USDA) Plum Island Animal Disease Center, a Biosafety Level 3 facility for research and diagnosis related to the world’s most dangerous livestock diseases. In that role, he initiated research on the genomic and functional genomic basis of disease pathogenesis, diagnosis, and control of livestock RNA and DNA virus infections. That work became the basis of U.S. defense against natural and deliberate infection with those and led to his involvement in the early 1990s in biologic-weapons defense and proliferation prevention. From 1995 to 1998, Dr. Breeze directed research programs in 20 laboratories in the Southeast for the USDA Agricultural Research Service before going to Washington, D.C., to establish biologic-weapons defense research programs for USDA. He received the Distinguished Executive Award from President Clinton in 1998 for his work at Plum Island and in biodefense. Since 2004, he has been chief executive officer of Centaur Science Group, which provides consulting services in biodefense. His main commitment is to the Defense Threat Reduction Agency’s

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

Biological Weapons Proliferation Prevention Program in Europe, the Caucasus, and Central Asia.


Dr. R. Mark Buller is widely recognized as a leader in the field of viral pathogenesis. His current research focuses on the interplay between the genetic expression of orthopoxviruses—such as monkeypox virus, ectromelia virus, and vaccinia virus—and the hosts’ response to infection. Dr. Buller applies this work to the development of animal models for the evaluation of antivirals and vaccines for smallpox. He currently serves as a professor at Saint Louis University, Missouri, in the Department of Molecular Microbiology and Immunology. Dr. Buller is also director of the Aerosol Biology Core of the multi-institutional Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases Research. Before joining Saint Louis University, he was head of the Poxvirus Pathogenesis Group at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Dr. Buller holds a PhD in virology from the Institute of Virology in Glasgow. He has published over 130 peer-reviewed scientific articles, reviews, and book chapters, and is a member of the editorial review boards of major scientific publications. Dr. Buller has also served as an invited reviewer, committee member, or speaker on the topic of bioterrorism and biomedical research.


Dr. Sean R. Eddy is a group leader at the Howard Hughes Medical Institute’s Janelia Farm Research Campus outside Washington, D.C. His research interests are in the development of computational algorithms for genome-sequence analysis. He is the author of several widely used software tools for biologic sequence analysis, including a software package called HMMER; a coauthor of the Pfam database of protein domains; and a coauthor of the book Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids (Cambridge University Press, 1998). He received a bachelor’s degree from the California Institute of Technology and a PhD from the University of Colorado at Boulder, and he was a postdoctoral fellow at NeXagen Pharmaceuticals and at the MRC Laboratory of Molecular Biology. He was on the faculty of the Department of Genetics of the Washington University School of Medicine for 11 years before moving to Janelia Farm.


Dr. Stanley Falkow is the Robert W. and Vivian K. Cahill Professor of Microbiology and Immunology at Stanford University School of Medicine. He formulated molecular Koch’s postulates, which have guided the study of the microbial determinants of infectious diseases since the late 1980s. Dr. Falkow received his BS from the University of Maine and went on to earn his PhD from Brown University. He discovered that infectious microorganisms use genes that are activated only inside host cells. Dr. Falkow has published numerous articles and has served on the editorial boards of several professional publications. In

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

addition, he has received numerous awards for his achievements in science, including the Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research, the Altemeier Medal from the Surgical Infectious Diseases Society of America, the Howard Taylor Ricketts Award Lecture at the University of Chicago, and the Paul Ehrlich–Ludwig Darmstaedter Prize. In 2003, he received the Abbott Lifetime Achievement Award from the American Society for Microbiology and the Selman A. Waksman Award in Microbiology from the National Academy of Sciences (NAS). He received the Robert Koch Award in 2000. Dr. Falkow was president of the American Society for Microbiology in 1997–1998. He was elected to the Institute of Medicine in 1997 and received the Maxwell-Finland Award from the National Foundation for Infectious Diseases in 1999. Also in 1999, he was named an honorary doctor of science by the University of Guelph, Canada, and received the University of Maine Alumni Career Award. He has received honorary doctorates in Europe and the United States. Dr. Falkow is a member of NAS and the National Academy of Arts and Sciences. He is also an elected fellow of the American Association for the Advancement of Science and a foreign member of the UK Royal Society. Dr. Falkow was nominated twice for a Nobel Prize in physiology or medicine. In 2008, Dr. Falkow received the Lasker Award for medical research.


Ms. Rachel E. Levinson, a 25-year veteran of science policy at the national level, is the director of the Arizona State University (ASU) Washington office and is responsible for special projects and research initiatives in the Office of the Vice President for Research and Economic Affairs. She joined ASU in 2005 as the director of the Government and Industry Liaison Office, Biodesign Institute at Arizona State University. Ms. Levinson heads an office responsible for facilitating mutually beneficial relationships between university researchers, federal funding agencies, and private-sector entities. Most recently, she was with the Office of Science and Technology Policy in the Executive Office of the President, where she was assistant director of life sciences. She began her career as a biologist at the National Cancer Institute of the National Institutes of Health (NIH). She advanced to become deputy director of the NIH Office of Recombinant DNA and senior policy adviser in the Office of Technology Transfer. Ms. Levinson earned her BS in zoology from the University of Maryland at College Park and her MA in science, technology, and public policy from the George Washington University School of Public and International Affairs.


Dr. John Mulligan founded Blue Heron Biotechnology in 1999 after a decade of genomics research, including establishment and management of one of the two Human Genome Centers at Stanford University and direction of genomics research at Darwin Molecular. Blue Heron Biotechnology is a pioneer in and leader of the gene-synthesis market.

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

Dr. Alison D. O’Brien is a professor in and chair of the Department of Microbiology and Immunology at the Uniformed Services University of the Health Sciences. She is a past president of the American Society for Microbiology. She received her PhD from Ohio State University in 1976. Research in Dr. O’Brien’s laboratory focuses on the molecular mechanisms by which the Shiga toxins from enterohemorrhagic Escherichia coli (EHEC) contribute to hemorrhagic colitis and the hemolytic uremic syndrome, the involvement of toxins from uropathogenic E. coli (UPEC) in the host response to urinary tract infections, and development of therapeutics against infections caused by Bacillus anthracis and B. cereus.


Dr. Francisco Ochoa-Corona, a forensic plant pathologist, specializes in delivering and developing reference diagnostics for exotic, naturalized, and indigenous plant viruses and other phytopathogens of relevance to agricultural biosecurity. His work is applicable to plant pathogens that can be intercepted at the border or detected through general surveillance in field settings or in transitional facilities. Dr. Ochoa-Corona’s research in plant pathology contributes scientific input to regulatory officials regarding plant health emergencies. He joined Oklahoma State University in 2008 from the Investigation and Diagnostic Centre of Biosecurity New Zealand, in the Ministry of Agriculture and Forestry, where he was principal adviser in virology.


Prof. Jane S. Richardson earned a bachelor’s degree from Swarthmore College and a master’s degree from Harvard University in 1966. Since 1970, she has been at Duke University Medical Center, where she and her husband, David, work together in investigating the three-dimensional structure of proteins and RNA. They were early pioneers in protein crystallography, in molecular computer graphics, and in the field of de novo protein design, proposing and then making novel amino-acid sequences designed to fold into specific 3D structures. Prof. Richardson was the developer of ribbon drawings of protein structures, originally done by hand but since universally adopted in molecular graphics. She identified many well-known structural motifs, such as the helix N-cap, and has recently concentrated on new methods for the validation and improvement of protein and RNA crystal structures. She became a MacArthur Fellow in 1985, a member of the National Academy of Sciences in 1991, and a member of the Institute of Medicine in 2006, and she was an assessor for last year’s CASP8 structure predictions.


Dr. Margaret Riley is a professor of biology at the University of Massachusetts Amherst (Umass Amherst). She received her PhD in population genetics from Harvard University and performed postdoctoral research in microbial population genetics with a Sloan Postdoctoral Fellowship in Molecular Evolution. She

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

joined the faculty of Yale in 1991 and recently moved to UMass Amherst. She has a broad set of research interests that range from studies of experimental evolution of microorganisms to development of novel antimicrobials and redefinition of the microbial species concept. Dr. Riley studies the evolution of microbial diversity with an emphasis on the ecology and evolution of microbial toxins. Her recent work has revealed that the production of toxins is a primary force in the generation and maintenance of microbial diversity. Those studies led to an interest in applying ecologic and evolutionary theory to the design of novel antimicrobials for use in animal and human health. She is cofounder of Origin Antimicrobials, Inc., whose mission is to discover and refine novel antimicrobials to address the challenge of antibiotic resistance. Dr. Riley is the director of the Organismic and Evolutionary Biology Program and the director of the Museum of Natural History at UMass Amherst. From 1999 to 2002, she chaired the Gordon conference on molecular evolution; from 2003 to 2005, she chaired the Gordon conference on microbial population biology and evolution. She is a fellow of the American Academy of Microbiology.


Mr. Tom Slezak has been involved with bioinformatics at Lawrence Livermore National Laboratory (LLNL) for 30 years after receiving a BS and an MS in computer science from the University of California, Davis. He is currently the associate program leader for informatics for the Global Security Program efforts at LLNL. He was involved in the Human Genome Program from 1987 to 2000, leading the informatics efforts at LLNL and then the Department of Energy Joint Genome Institute from 1997 to 2000. In 2000, he began to build a pathogen bioinformatics team at LLNL, pioneering a novel whole-genome analysis approach to DNA signature design. His team developed signature targets for multiple human pathogens that were used at the 2002 Winter Olympic Games under the BASIS program and later adapted for use nationwide in the Department of Homeland Security (DHS) BioWatch program. Under a close collaboration with the Centers for Disease Control and Prevention, the LLNL team has been called on for computational help on smallpox, SARS, monkey-pox, avian influenza, and numerous other diseases. In addition to continuing work on human and agricultural pathogens, Mr. Slezak team is focusing on signatures of mechanisms of virulence, antibiotic resistance, and evidence of genetic engineering. They have been working on detecting novel, engineered, and advanced biothreats for several years, leveraging high-risk Information Technology Industry Council and DHS funding. Mr. Slezak has chaired or served on multiple advisory boards, including those of the rice genome project, mouse and maize genetics databases, the spruce tree genome project (Canada), plant pathogens, and a National Institute of Allergy and Infectious Diseases sequencing center contract renewal.

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

NATIONAL RESEARCH COUNCIL STAFF

Dr. India Hook-Barnard is a program officer with the Board on Life Sciences of the National Research Council. She came to the National Academies from the National Institutes of Health where she was a Postdoctoral Research Fellow from 2003 to 2008. Her research investigating the molecular mechanism of gene expression focused on the interactions between RNA polymerase and promoter DNA. Dr. Hook-Barnard earned her PhD from the Dept. of Molecular Microbiology and Immunology at the University of Missouri. Her graduate research examined translational regulation and ribosome binding in Escherichia coli. At the National Academies, she contributes to projects in a variety of exciting topic areas. Much of her current work is related to issues of biosecurity, microbiology, and genomics. She is the study director or staff officer for several ongoing projects including the U.S. Canada Regional Committee for the International Brain Research Organization, Animal Models for Assessing Countermeasures to Bioterrorism Agents, and Framework for Developing a New Taxonomy of Disease.


Mr. Carl-Gustav Anderson is a senior program assistant with the Board on Life Sciences of the National Research Council. He received a BA in philosophy from American University in 2009, completing significant research projects exploring on the philosophy of the Kyoto School. He has worked closely with the All Women’s Action Society (Malaysia), helping to engage young men in feminist dialogue and to present a feminist response to the unique identity politics of contemporary Malaysia. He has focused his research interests on Buddhist encounters with the West, with particular emphasis on Buddhist responses to Western feminism, communism, transcendental philosophy, and existentialism.

Since joining the Board on Life Sciences in 2009, he has served as senior program assistant for Responsible Research with Biological Select Agents and Toxins (2009) and Challenges and Opportunities for Education about Dual Use Issues in Life Sciences Research (2010). In addition to several consensus committees, he also serves as senior program assistant for the United States-Canada Regional Committee to the International Brain Research Organization.

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×

This page intentionally left blank.

Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 137
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 138
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 139
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 140
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 141
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 142
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 143
Suggested Citation:"Appendix B: Committee Member and Staff Biographies." National Research Council. 2010. Sequence-Based Classification of Select Agents: A Brighter Line. Washington, DC: The National Academies Press. doi: 10.17226/12970.
×
Page 144
Next: Appendix C: HHS and USDA Select Agents and Toxins »
Sequence-Based Classification of Select Agents: A Brighter Line Get This Book
×
Buy Paperback | $69.00 Buy Ebook | $54.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Select Agents are defined in regulations through a list of names of particularly dangerous known bacteria, viruses, toxins, and fungi. However, natural variation and intentional genetic modification blur the boundaries of any discrete Select Agent list based on names. Access to technologies that can generate or 'synthesize' any DNA sequence is expanding, making it easier and less expensive for researchers, industry scientists, and amateur users to create organisms without needing to obtain samples of existing stocks or cultures. This has led to growing concerns that these DNA synthesis technologies might be used to synthesize Select Agents, modify such agents by introducing small changes to the genetic sequence, or create entirely new pathogens. Amid these concerns, the National Institutes of Health requested that the Research Council investigate the science and technology needed to replace the current Select Agent list with an oversight system that predicts if a DNA sequence could be used to produce an organism that should be regulated as a Select Agent.

A DNA sequence-based system to better define when a pathogen or toxin is subject to Select Agent regulations could be developed. This could be coupled with a 'yellow flag' system that would recognize requests to synthesize suspicious sequences and serve as a reference to anyone with relevant questions, allowing for appropriate follow-up.

Sequence-Based Classification of Select Agents finds that replacing the current list of Select Agents with a system that could predict if fragments of DNA sequences could be used to produce novel pathogens with Select Agent characteristics is not feasible. However, it emphasized that for the foreseeable future, any threat from synthetic biology and synthetic genomics is far more likely to come from assembling known Select Agents, or modifications of them, rather than construction of previously unknown agents. Therefore, the book recommends modernizing the regulations to define Select Agents in terms of their gene sequences, not by their names, and called this 'sequence-based classification.'

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!